PagnatoKarp Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,832	Closed	-$247K	–	31
2020 Q1	$247K	Buy	5,832 +2,416	+71%	+$102K	0.06%	135
2019 Q4	$208K	Buy	+3,416	New	+$208K	0.04%	177